J. Angus et al., THE BRN-2 GENE REGULATES THE MELANOCYTIC PHENOTYPE AND TUMORIGENIC POTENTIAL OF HUMAN-MELANOMA CELLS, Oncogene, 11(4), 1995, pp. 691-700
The Oct transcription factors N-Oct-3 and N-Oct-5 are differentially e
xpressed in normal melanocytes, melanoma tumors and cell lines. We hav
e cloned the human brn-2 gene and have shown that it encodes both the
N-Oct-3 and N-Oct-5 octamer binding activities detected in melanoma ce
lls. The brn-2 genomic locus has been mapped to chromosome 6q16 and al
though chromosomal aberrations are common in this region in melanoma,
no deletion or rearrangement of the brn-2 gene in melanoma cell lines
was observed. Sequencing of the entire gene showed that there are no i
ntervening sequences within the open reading frame. Antisense RNA-medi
ated inhibition of brn-2 gene expression in melanoma cells was associa
ted with a change in morphology and loss of melanocytic and neural cre
st markers, including the melanocyte transcription factor microphthalm
ia and the TYRP pigmentation genes. In addition, loss of brn-2 in thes
e cells resulted in the complete loss of ability to form tumors in SCI
D and nu/nu mice. These results suggest roles for brn-2 in the determi
nation of the melanocytic lineage and in the tumorigenic phenotype of
melanoma.